The DEFINE study: a bright future for CETP inhibitors?

Expert Opin Investig Drugs. 2011 Mar;20(3):311-4. doi: 10.1517/13543784.2011.550571. Epub 2011 Jan 17.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticholesteremic Agents / pharmacology
  • Cholesterol Ester Transfer Proteins / antagonists & inhibitors*
  • Cholesterol, HDL / metabolism
  • Cholesterol, LDL / metabolism
  • Dyslipidemias / drug therapy*
  • Dyslipidemias / metabolism
  • Humans
  • Oxazolidinones / pharmacology*
  • Quinolines / pharmacology*

Substances

  • Anticholesteremic Agents
  • Cholesterol Ester Transfer Proteins
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Oxazolidinones
  • Quinolines
  • torcetrapib
  • anacetrapib